Safety of HEPLISAV™ Hepatitis B Virus Vaccine in End-stage Kidney Failure Patients

NCT00426712 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

42

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatitis B

Interventions

BIOLOGICAL: 1018 ISS immunostimulatory oligonucleotide with HBV surface antigen
BIOLOGICAL: Hepatitis B Vaccine (Recombinant)

Sponsor

Dynavax Technologies Corporation